Archives: Speakers

Benjamin Apelberg, PhD is the Deputy Director for Regulatory Science in the Office of Science at FDA’s Center for Tobacco Products (CTP). In this role, he oversees scientific divisions responsible for managing the Office’s tobacco regulatory science research program, including the Population Assessment of Tobacco and Health (PATH) study and collaboration with CDC on the National Youth Tobacco Survey; serving as expert reviewers and technical project leads (TPLs) for the premarket tobacco product application (PMTA) and modified risk tobacco product application (MRTPA) pathways; and providing scientific expertise in the fields of the health sciences, medicine, pharmacology, epidemiology, social science, evaluation, and statistics to support the Center’s tobacco product regulatory efforts.

Ron Ramos is a Senior Director of Business Development at EmVenio Clinical Research. He joined EmVenio in 2022, bringing more than six years of direct experience in the mobile visit space and over two decades in the biopharma industry. Ron began his career at the bench as a molecular biologist at Thomas Jefferson University, where he earned a Master’s degree in Biomedical Chemistry in 2003.

With his combined scientific foundation and operational expertise, Ron acts as a subject matter expert for clients, offering both analytical and practical perspectives on deploying mobile visits for complex, global clinical studies.

Aadil Bundeally is a seasoned transformation professional with over 20 years’ international experience across Banking, Wealth & Asset Management, Insurance, and Impact Investing. He brings deep industry knowledge spanning regulatory landscapes, operating models, organisational design, integrated systems and governance-risk-compliance frameworks. With relentless focus on customer advocacy, operational efficiency and results-driven innovation, underpinned by Data Analytics, RPA, AI-ML and Gen AI, he has deployed numerous platforms and solutions delivering significant cost reduction and quality-of-life improvements for customers, suppliers and staff. A firm believer in the three lines of defence, he maintains rigorous governance whilst managing complex multi-level stakeholder relationships and generating robust C-suite analysis. Experienced in product management, vendor selection, procurement oversight and dispute resolution, he has held senior roles at Lloyd’s of London, Virgin Money, Barclays and Lloyds Banking Group, leading diverse teams across consulting, interim and in-house engagements. He holds four postgraduate qualifications, including an MBA from Melbourne Business School and UCLA Anderson.

I have worked in clinical research since 2011 holding different roles across various departments. Most recently working as clinical research manager at UCSF Cancer Center, Clinical Research Network Office (CRNO), since 2021.

Originally from North Carolina, my interest in clinical research started in college working as a research assistant for burn and transplant research and continued after graduation working at a Contract Research Organization. After moving to NYC, I wanted to move to the patient side of research and worked as a Radiation Oncology Clinical Research Coordinator at Montefiore Medical Center. After gaining experience and knowledge, I worked in Radiation Oncology at Memorial Sloan Kettering Cancer Center initially spearheading our newly created Quality Assurance program, and then moved into a supervisor role managing Clinical Research Coordinators. After relocating to the Bay Area, I shifted gears working in allergy research clinical operations with the Immune Tolerance Network. After realizing I missed the world of oncology and management, I found my current role as an Associate Director of Clinical Research Programs in the UCSF Cancer Center managing several programs.